Latest Embolectomy Stories

When someone has a stroke, time equals brain. The longer a stroke is left untreated, the more brain tissue is lost. Since the only proven treatment — a clot-busting drug — works in less than half of patients, stroke physicians had high hopes for a mechanical device that could travel through the blocked blood vessel to retrieve or break up the clot, restoring blood flow to the brain. But in a recently completed multi-site trial in which UCLA served as the clinical coordinating center,...

Every 40 seconds, someone in the United States has a stroke, usually caused when a clot blocks an artery that supplies blood to the brain. Now the results of two multicenter studies published online in The Lancet on August 26 are giving physicians new innovative tools proven to better remove these clots that block blood flow. The TREVO 2 clinical trial, (Thrombectomy Revascularization of Large Vessel Occlusions in Acute Ischemic Stroke) showed that the Trevo Retriever, a clot-removal...

Stroke is the fourth leading cause of death and a common cause of long-term disability in the United States, but doctors have very few proven treatment methods. Now a new device that mechanically removes stroke-causing clots from the brain is being hailed as a game-changer. In a recent clinical trial, the SOLITAIRE Flow Restoration Device dramatically outperformed the standard mechanical treatment. Findings from the trial, called SOLITAIRE With the Intention for Thrombectomy (SWIFT), are...

PHILADELPHIA, May 11, 2012 /PRNewswire/ -- This new Q&A session features industry leaders Dean Kamen and Dr. Thomas Fogarty offering their insights into the future of medical device development. Free for attendees at MD&M East Philadelphia on May 23. On Wednesday, May 23 at 2:30pm, Medical Design & Manufacturing East (MD&M East) will present the special panel, "The Great Innovators: A Sit-Down Chat with Dr. Thomas Fogarty...

LOS ANGELES, March 29, 2012 /PRNewswire/ -- UBM Canon's Medical Design Excellence Awards (MDEA), the industry's premier awards ceremony for medical device design and innovation, has announced Dr. Thomas Fogarty as the recipient of the 2012 MDEA Lifetime Achievement Award. This award honors an individual whose contributions during a long career have had a demonstrable impact on technological, business, and cultural advancements in medical devices. Last year's recipient was Alfred E....

MOUNTAIN VIEW, Calif., Oct. 4, 2011 /PRNewswire/ -- Advance Research Associates (ARA), The Fogarty Institute for Innovation, Mountain View Chamber of Commerce, and the City of Mountain View, in cooperation with Fenwick and West, will hold a panel discussion entitled "Overcoming Challenges in Medical Device Development: An Honest Conversation." The event will be held on Thursday, October 13, 2011 at 7:30-9:30 AM at the Fenwick and West offices in Mountain View, CA (801 California Ave.)....

MOUNTAIN VIEW, Calif., June 14, 2011 /PRNewswire/ -- Hotspur Technologies, a leading developer of catheter-based technologies aimed at restoring blood flow for patients with obstructed vessels, today announced the appointment of Fred Khosravi to the newly-created position of Chairman of its Board of Directors. Mr. Khosravi, a Hotspur co-founder and current Director, will continue to work closely with the other Directors as well as Hotspur's President & CEO, Gwen Watanabe, in making the...

MOUNTAIN VIEW, Calif., May 6, 2011 /PRNewswire/ -- Hotspur Technologies, Inc. announced today that it has received CE Mark approval for the IQCath Balloon Dilatation Catheter, allowing the company to introduce the novel technology to markets outside of the United States. The IQCath catheter utilizes Hotspur's groundbreaking technology to combine multiple functions into a single device that can potentially make procedures to open blocked blood vessels more efficient and cost-effective than...

MOUNTAIN VIEW, Calif., Feb. 28, 2011 /PRNewswire/ -- Hotspur Technologies announced today that Dr. Thomas DiBartholomeo of Fairfield, CT, performed the first clinical use of its Keeper(TM) Embolectomy Catheter. The Keeper Catheter enables physicians to clear clot formation within arteries, while also incorporating the capability of injecting physician-specified fluids directly through the balloon catheter. The Keeper Catheter combines a compliant embolectomy balloon with its proprietary...

MOUNTAIN VIEW, Calif., Jan. 18, 2011 /PRNewswire/ -- Hotspur Technologies, Inc. announced today that Dr. Greg Sampognaro, Interventional Cardiologist at P & S Surgical Hospital in Monroe, Louisiana, successfully completed the first use of the GPSCath(TM) Balloon Dilatation Catheter in an intervention to treat a blocked peripheral artery. Successful use of the GPSCath Catheter in this type of procedure confirms the ability of this device to assist patients who suffer from peripheral...